Skip to content

PERSPECTIVE THERAPEUTICS, INC.

CATX

CIK 0000728387

← back to feed
Revenue (TTM)
$8.05M
−13.9% YoY Q1 May 2026
Net Income (TTM)
−$91.82M
−30.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.14
−13.8% YoY Q1 May 2026
Gross Margin
23.4%
Q1 May 2026
Operating Margin
-1,266.8%
Q1 May 2026
Net Margin
-1,140.2%
Q1 May 2026
Free Cash Flow (TTM)
−$69.71M
Q1 May 2026
Cash
$53.97M
Q1 May 2026
Total Debt
$1.61M
Q1 May 2026
Shares Outstanding
114.05M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings